Qilu Pharmaceutical
Manufacturing · China · 11-50 Employees
View Company Info for Free
Overview
Headquarters
8888 Lvyou Rd, Jinan, Shandong, 250104, ...Phone Number
+86 53183127705Website
www.qilu-pharma.comRevenue
$7.2 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
1
1
1
1
1
About Qilu Pharmaceutical
Qilu Pharmaceutical is a leading vertically integrated pharmaceutical company in China, specializing in the development, manufacturing, and marketing of active pharmaceutical ingredients (APIs) and finished formulations. With over 300 marketed products, including 55 first-to-launch in China, the company has a robust pipeline of generic, innovative, and biosimilar products. Qilu operates 12 subsidiaries and 11 manufacturing sites, employing over 39,000 people globally, and exports its products to more than 100 countries. The company is committed to providing affordable medicines and improving global health through innovative research and development.Explore more
Qilu Pharmaceutical Org Chart
JJ
Senior and Executive Director, Pre-clinical P...
SZ
Director, Clinical Pharmacology
CD
Director for Translational Medicine
FM
Associate BD Director, Qilu Innovative Pharma...
HW
Associate Medical Director
RZ
Associate Director, International Business Ap...
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Qilu Pharmaceutical your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Qilu Pharmaceutical recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Qilu Pharmaceutical, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Click to see if Qilu Pharmaceutical had a recent Job posting/layoffs
Product Launch: Get notified when Qilu Pharmaceutical launches new products
Check out if Qilu Pharmaceutical is spiking on competitors!
Check if Qilu Pharmaceutical has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Qilu Pharmaceutical has new funding data
Congratulate Masked Content for being promoted to Masked Content at Qilu Pharmaceutical
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Company Profile Activity
Activity Insights
Qilu Pharmaceutical is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Qilu Pharmaceutical is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Qilu Pharmaceutical.
Qilu Pharmaceutical Tech Stack
A closer look at the technologies used by Qilu Pharmaceutical
See more technologies
Most Recent Scoops
Hiring Plans
Qilu Pharmaceutical has more open roles in Engineering & Technical than it has had at any time in the past 12 months. Areas of expertise include: Nucleic Acids, Strategic Partnership, Large Molecules, Research And Development, Small Molecules, and Strategic Decision Making.
Hiring Plans
Event
Product Marketing, Events, Training, Sales, Logistics / Supply Chain, Pharmaceuticals, Clinical Operations, Field Marketing, Manufacturing Operations, Operations
Partnership
Project
Partnership, Product Management, Business Development, Pharmaceuticals
Partnership
Partnership, Product Management, Sales Development
Left Company
Executive Move
Qilu Pharmaceutical News & Media
Preliminary Results of Qilu Pharmaceutical's Phase Ia Study on GPRC5D/CD3-Targeting Bispecific Antibody QLS32015 Unveiled at 2024 ASH Annual Meeting
JINAN, China, Dec. 25, 2024 /PRNewswire/ -- During the 66th Annual Meeting of the American Society of Hematology (ASH) held in San Diego from December 7 to 10, preliminary results from the first human trial of QLS32015, a novel anticancer drug developed by Qilu Pharmaceutical for treating relapsed/refractory multiple myeloma (RRMM), were unveiled (Poster Number: 1990). The findings demonstrated that QLS32015 showed excellent anti-tumor activity and was well tolerated by patients with RRMM. SchemLisata Therapeutics and Qilu Pharmaceutical Announce First Patient Treated in Qilu’s Phase 2 Trial in China of LSTA1 in Patients with Metastatic Pancreatic Ductal Adenocarcinoma
Results of Phase 1b/2 in China reinforce global clinical development rationale and plans for LSTA1 Results of Phase 1b/2 in China reinforce global clinical development rationale and plans for LSTA1Results from the Clinical Trial of Qilu Pharmaceutical's Novel Anticancer Agent Iparomlimab and Tuvonralimab (QL1706) Featured in Oral Presentation at the ESGO Annual Meeting
JINAN, China, March 4, 2024 /PRNewswire/ -- The European Society of Gynecological Oncology (ESGO) 2024 Conference has recently made selected abstracts available online. The abstract (abstract # 251) that details results from the Phase II clinical trial (DUBHE-C-206) evaluating the efficacy and safety of Qilu Pharmaceuticals' iparomlimab and tuvonralimab (QL1706) in cervical cancer was selected for oral presentation on 8 March, local time. Access the abstract here: https://emma.events/site/prograQiLu Pharmaceutical's Iruplinalkib Phase III INSPIRE Study Researched Primary Endpoint and was Selected for 2023 WCLC Oral Presentation
JINAN, China, Aug. 17, 2023 /PRNewswire/ -- August 16, 2023, at the 2023 World Conference on Lung Cancer (WCLC), the complete list of selected abstracts was announced, among which QiLu Pharmaceutical's iruplinalkib phase III clinical trial (INSPIRE) results were chosen for oral...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Qilu Pharmaceutical
Sign Up For FreeTo access detailed company insights
Qilu Pharmaceutical is a leading vertically integrated pharmaceutical company in China, specializing in the development, manufacturing, and marketing of active pharmaceutical ingredients (APIs) and finished formulations. With over 300 marketed products, including 55 first-to-launch in China, the company has a robust pipeline of generic, innovative,... Read More
